BioSpace News Archive

The newly formed Scientific Advisory Board (SAB) of Europital – a globally-focused, full-service CRO serving small and mid-tier innovators – forewarns that a clinical knowledge deficit amongst smaller biotechs will potentially slow trials in 2021.

Products Listing CBD as Inactive Ingredient Cited for Unapproved Drug and Misbranding Violations

Terragenx Inc. has developed a unique production and delivery system that is 9x more effective than a capsule form, to deliver iodine

RADx-rad STTR award will help the company develop their radical technology for regulatory approval and product launch.

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant IONTAS now seeking development partners

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has received the official minutes from a Type B pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) on its development plan for TNX-601 CR

It is with tremendous sadness that Cerner Corporation announces that Linda M. Dillman, a long-time and trusted board member, passed away on Saturday, March 13.

Four-part, patient-focused toolkit is available for download at no cost and allows sponsors to identify risks to the efficiency and success of their trials

Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that it will report financial results for the fourth quarter and full year 2020 after market close on March 29, 2021

Akero Therapeutics, Inc. announced that the company plans to discuss new efficacy and safety data, including biopsy results, from an expansion cohort of a 16-week Phase 2a clinical trial, Cohort C, evaluating efruxifermin in the treatment of adult patients with cirrhotic nonalcoholic steatohepatitis in a post-market press release and webcast to be held today, March 22, 2021.